» Articles » PMID: 27086571

Clinical Outcomes in Overweight Heart Transplant Recipients

Overview
Journal Heart Lung
Date 2016 Apr 19
PMID 27086571
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Few studies have examined the impact of patient weight on heart transplant (HT) outcomes.

Objectives: Nine outcomes were compared in 2 groups of HT recipients (N = 347) based on their mean body mass index (BMI) during the first 3 years post-HT.

Methods: Group 1 consisted of 108 non-overweight patients (BMI <25; mean age 52; 29.6% females; 16.7% minorities). Group 2 consisted of 239 overweight patients (BMI ≥25; mean age 52; 15.9% females; 13.8% minorities). Outcomes were: survival, re-hospitalization, rejections, infections, cardiac allograft vasculopathy (CAV), stroke, renal dysfunction, diabetes, and lymphoma.

Results: Non-overweight patients had shorter survival, were re-hospitalized more days after the HT discharge, and had more lymphoma and severe renal dysfunction. Overweight patients had more CAV, steroid-induced diabetes, and acute rejections.

Conclusions: Overweight HT patients had better survival, but more rejections, CAV, and diabetes. Non-overweight HT patients had worse survival, plus more re-hospitalization time, lymphoma, and renal dysfunction.

Citing Articles

Impact of Donor-Recipient BMI Ratio on Survival Outcomes of Heart Transplant Recipients: A Retrospective Analysis Study.

Zhong Y, Zhang C, Wang Y, Liu M, Shang X, Dong N Clin Cardiol. 2024; 47(9):e70010.

PMID: 39233528 PMC: 11375284. DOI: 10.1002/clc.70010.


Cardio-Renal-Metabolic Outcomes Associated With the Use of GLP-1 Receptor Agonists After Heart Transplantation.

Donald E, Driggin E, Choe J, Batra J, Vargas F, Lindekens J Clin Transplant. 2024; 38(7):e15401.

PMID: 39023081 PMC: 11634378. DOI: 10.1111/ctr.15401.


Implications of obesity across the heart failure continuum.

Elagizi A, Carbone S, Lavie C, Mehra M, Ventura H Prog Cardiovasc Dis. 2020; 63(5):561-569.

PMID: 33002458 PMC: 7521376. DOI: 10.1016/j.pcad.2020.09.005.


Sleeve Gastrectomy in Patients with Continuous-Flow Left Ventricular Assist Devices: a Systematic Review and Meta-Analysis.

Challapalli J, Maynes E, OMalley T, Cross D, Weber M, Choi J Obes Surg. 2020; 30(11):4437-4445.

PMID: 32654017 DOI: 10.1007/s11695-020-04834-4.


Healthy Hearts via Live Videoconferencing: An Exercise and Diet Intervention in Pediatric Heart Transplant Recipients.

Chen A, Ramirez F, Rosenthal D, Couch S, Berry S, Stauffer K J Am Heart Assoc. 2020; 9(3):e013816.

PMID: 31973598 PMC: 7033874. DOI: 10.1161/JAHA.119.013816.

References
1.
Thomas H, Banner N, Murphy C, Steenkamp R, Birch R, Fogarty D . Incidence, determinants, and outcome of chronic kidney disease after adult heart transplantation in the United Kingdom. Transplantation. 2012; 93(11):1151-7. DOI: 10.1097/TP.0b013e31824e7620. View

2.
Grady K, Jalowiec A, White-Williams C . Preoperative psychosocial predictors of hospital length of stay after heart transplantation. J Cardiovasc Nurs. 1999; 14(1):12-26. DOI: 10.1097/00005082-199910000-00003. View

3.
Mogollon Jimenez M, Sobrino Marquez J, Arizon Munoz J, Sanchez Brotons J, Guisado Rasco A, Hernandez Jimenez M . Incidence and importance of de novo diabetes mellitus after heart transplantation. Transplant Proc. 2008; 40(9):3053-5. DOI: 10.1016/j.transproceed.2008.09.045. View

4.
Augustine S, Baumgartner W, Kasper E . Obesity and hypercholesterolemia following heart transplantation. J Transpl Coord. 1998; 8(3):164-9. DOI: 10.7182/prtr.1.8.3.eg2p05773u818q54. View

5.
Valantine H . Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant. 2004; 23(5 Suppl):S187-93. DOI: 10.1016/j.healun.2004.03.009. View